Home » Impurities » Mirtazapine

Mirtazapine

Mirtazapine Impurities & Reference Standards

Mirtazapine is recognized as an active pharmaceutical ingredient (API) that supports formulation development, process validation, and quality assurance in drug manufacturing. The compound carries the molecular formula C17H19N3, corresponding to a molecular weight of 265.35 g/mol. Analytical laboratories rely on Mirtazapine and its associated impurity standards for method development, quality control testing, and pharmacopoeial compliance (ICH, USP, BP, EP). Each batch of Mirtazapine reference standard is accompanied by a Certificate of Analysis (CoA), HPLC purity data, and spectroscopic (NMR/MS/IR) characterization for use in pharmaceutical laboratories worldwide.


Associated Impurities

Mirtazapine Cyano Oxalate Impurity

  • CAS No: 61337-88-0
  • Mol. F.: C17H19N3

Mirtazapine Impurity – A

  • CAS No: 155172-12-6
  • Mol. F.: C17H19N3

Mirtazapine Impurity – C

  • CAS No: 191546-96-0
  • Mol. F.: C17H19N3

Mirtazapine Impurity – D

  • CAS No: 61337-68-8
  • Mol. F.: C17H19N3

Mirtazapine Impurity – E

  • CAS No: 191546-94-8
  • Mol. F.: C17H19N3

Mirtazapine Impurity – F

  • CAS No: 191546-97-1
  • Mol. F.: C17H19N3
Scroll to Top